Abstract
The term dry eye was initially introduced by Roetth in 1953, who described dry eye as low flow of tears measured with the Schirmer test (de Roetth 1953). Now in the twenty-first century, our understanding of the underlying mechanisms and multiple possible etiologies underlying this form of ocular surface disease is more complex and nuanced, but the term “dry eye” is still prevalently used worldwide (Morube 2004).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albietz JM, Lenton LM, McLennan SG (2004) Chronic dry eye and regression after laser in situ keratomileusis for myopia. J Cataract Refract Surg 30:675–684
Aragona P, Papa V, Micali A et al (2002) Long term treatment with sodium hyaluronate containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 86:181–184
Aragona P, Bucolo C, Spinella R et al (2005) Systemic oomega-6 essential fatty acid treatment and PGE1 tear content in Sjögren’s syndrome patients. Invest Ophthalmol Vis Sci 46:4474–4479
Avni I, Garzozi HJ, Barequet IS et al (2010) Treatment of dry eye syndrome with orally administered CF101- data from a phase 2 clinical trial. Ophthalmology 117:1287–1293
Barabino S, Rolando M, Camicione P et al (2003) Systemic linoleic and γ-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea 22:97–101
Bashour M, Harvey J (2000) Causes of involutional ectropion and entropion- age related tarsal changes are the key. Ophthal Plast Reconstr Surg 16:131–141
Baudouin C (2001) The pathology of dry eye. Surv Ophthalmol 45:S211–S220
Behrens A, Doyle JJ, Stern L et al (2006) Dysfunctional tear syndrome- a Delphi approach to treatment recommendations. Cornea 25:900–907
Bron AJ, Tiffany JM (2004) The contribution of meibomian disease to dry eye. Ocul Surf 2:149–164
Burns E, Mulley GP (1992) Practical problems with eye-drops among elderly ophthalmology outpatients. Age Ageing 21:168–170
Chen SX, Lee GA (2007) SmartPlug in the management of severe dry eye syndrome. Cornea 26:534–538
Cho YK, Kim MS (2009) Dry eye after cataract surgery and associated intraoperative risk factors. Korean J Ophthalmol 23:65–73
Damasceno RW, Osaki MH, Dantas PEC et al (2011) Involutional entropion and ectropion of the lower eyelid: prevalence and associated risk factors in the elderly population. Ophthal Plast Reconstr Surg 27:317–320
de Paiva CS, Pflugfelder SC (2008) Rationale for anti-inflammatory therapy in dry eye syndrome. Arq Bras Oftalmol 71:S89–S95
de Paiva CS, Corrales RM, Villarreal AL (2006) Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res 83:526s–535s
de Roetth AFM (1953) Low flow of tears- the dry eye. Am J Ophthalmol 35:782–787
Department of Health and Human Services (2010) Distribution of age at diagnosis of diabetes among adult incident cases aged 18–79 years, United States, 2008. http://www.cdc.gov.proxy3.library.jhu.edu/diabetes/statistics/age/fig1.htm. Accessed 6 Dec 2011
Di Pascuale MA, Espana EM, Kawakita T et al (2004) Clinical characteristics of conjunctivochalasis with or without aqueous tear deficiency. Br J Ophthalmol 88:388–392
Dogru M, Katakami C, Inoue M (2001) Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 108:586–592
Foulks GN (2006) Topical cyclosporine for treatment of ocular surface Disease. Int Ophthalmol Clin 46:105–122
Fox RI (2005) Sjögren’s syndrome. Lancet 366:321–331
Friedman NJ (2010) Impact of dry eye disease and treatment on quality of life. Curr Opin Ophthalmol 21:310–316
Galor A, Feuer W, Lee DJ et al (2011) Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population. Am J Ophthalmol 152:377–384
Gilbard JP (2009) Dry eye blepharitis: approaching the patient with chronic eye irritation. Geriatrics 6:22–26
Guillon M, Maissa C (2008) Contact lens wear affects tear film evaporation. Eye Contact Lens 34:326–330
Henstrom DK, Lindsay RW, Cheney ML et al (2011) Surgical treatment of the periocular complex and improvement of quality of life in patients with facial paralysis. Arch Facial Plast Surg 13:125–128
Jaworowski S, Drabkin E, Rozenman Y (2002) Xerophthalmia and undiagnosed eating disorder. Psychosomatics 43:506–507
Kojima T, Dogru M, Ishida R et al (2006) Clinical evaluation of the SmartPlug TM in the treatment of dry eyes. Am J Ophthalmol 141:386–387
Lemp MA (1994) Management of the dry-eye patient. Int Ophthalmol Clin 34:101–113
Lemp MA (1995) Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry eyes. CLAO J 21:221–232
Lemp MA (2008a) Advances in understanding and managing dry eye disease. Am J Ophthalmol 146:350–356
Lemp MA (2008b) Management of dry eye disease. Am J Manag Care 14:S88–S101
Lemp MA, Baudouin C, Baum J et al (2007) The definition and classification of dry eye disease: report of Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 5:75–92
Lépine JP, Bouchez S (1998) Epidemiology of depression in the elderly. Int Clin Psychopharmacol 13:S7–S12
Li M, Gong L, Sun X et al (2011) Anxiety and depression in patients with dry eye syndrome. Curr Eye Res 36:1–7
Lin PY, Tsai SY, Cheng CY et al (2003) Prevalence of dry eye among an elderly Chinese population in Taiwan- the Shihpai Eye Study. Ophthalmology 110:1096–1101
Liu H, Begley C, Chen M et al (2009) A link between tear instability and hyperosmolarity in dry eye. Arch Ophthalmol 127:763–768
Luo L, Li D, Pflugfelder SC (2007) Hyperosmolarity- induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways. Cornea 26:452–460
Manaviat MR, Rashidi M, Afkahami-Ardekani M et al (2008) Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol 8(10)
Mantelli F, Tranchina L, Lambiase A et al (2011) Ocular surface damage by ophthalmic compounds. Curr Opin Allergy Clin Immunol 11:464–470
Marsh P, Pflugfelder SC (1999) Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome. Ophthalmology 106:811–816
Mathers WA, Lane JA (1998) Meibomian gland lipids, evaporation and tear film stability. Adv Exp Med Biol 438:349–360
Miljanovic B, Trivedi KA, Dana MR et al (2005) Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 82:887–893
Miljanovic B, Dana R, Sullivan DA et al (2007) Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 143:409–415
Morube J (2004) Andrew de Roetth (1893–1981): dacryologist who introduced the term dry eye. Ocul Surf 2:225–227
Moss SE, Klein R, Klein BEK (2000) Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118:1264–1268
Murray MD, Morrow DG, Weiner M et al (2004) A conceptual framework to study medication adherence in older adults. Am J Geriatr Pharmacother 2:36–43
Nichols KK, Nichols JJ, Mitchell GL (2004) The lack of association between signs and symptoms patients with dry eye disease. Cornea 23:762–770
Niti M, Ng TP, Kua EH et al (2007) Depression and chronic medical illnesses in Asian older adults: the role of subjective health and functional status. Int J Geriatr Psychiatry 22:1087–1094
Ono M, Takamura E, Shinozaki K et al (2004) Therapeutic effect of cevimeline on dry eye in patients with Sjögren’s syndrome: a randomized, double-blind clinical study. Am J Ophthalmol 138:6–17
Patane MA, Cohen A, From S et al (2011) Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial. Clin Ophthalmol 5:633–643
Pflugfelder SC, Maskin SL, Anderson B et al (2007) A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5 %, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol 138:444–457
Pflugfelder SC, Geerling G, Kinoshita S et al (2007) Management and therapy of dry eye disease: Report of the management and therapy subcommittee of the international dry eye workshop. Ocular surface 5:163–178
Roberts CW, Carniglia PE, Brazzo BG (2007) Comparison of topical cyclosporine, punctual occlusion, and a combination for the treatment of dry eye. Cornea 26:805–809
Rosenthal P, Corteau A (2005) Fluid-ventilated, gas-permeable sclera contact lens is an effective option for managing severe ocular surface disease and many corneal disorders that would otherwise require penetrating keratoplasty. Eye Contact Lens 31:130–134
Rossi GCM, Tinelli C, Pasinetti GM et al (2009) Dry eye syndrome-related quality of life in glaucoma patients. Eur J Ophthalmol 19:572–579
Schaumberg DA, Buring JE, Sullivan DA et al (2001) Hormone replacement therapy and dry eye syndrome. JAMA 286:2114–2119
Schaumberg DA, Sullivan DA, Buring JE et al (2003) Prevalence of dry eye syndrome among US women. Am J Ophthalmol 136:318–326
Schaumberg DA, Dana R, Buring JE et al (2009) Prevalence of dry eye disease among US men. Arch Ophthalmol 127:763–768
Schein OD, Tielsch JM, Munoz B et al (1997) Relation between signs and symptoms of dry eye in the elderly- a population-based perspective. Ophthalmology 104:1395–1401
Semba CP, Torkildsen GL, Lonsdale JD et al (2012) A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist SAR 1118 for the treatment of dry eye. Am J Ophthalmol 153:1050–1060
Shimmura S, Ono M, Shinozaki K et al (1995) Sodium hyaluronate eyedrops in the treatment of dry eyes. Br J Ophthalmol 79:1007–1011
Shine WE, McCulley JP, Pandya AG (2003) Minocycline effect on meibomian gland lipids in meibomianitis patients. Exp Eye Res 76:417–420
Smith VA, Cook SD (2004) Doxycycline- a role in ocular surface repair. Br J Ophthalmol 88:619–625
Smith JA, Albeitz J, Begley C et al (2007) The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop. Ocul Surf 5:93–107
Snibson GR, Greaves JL, Soper NDW et al (1990) Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy. Eye 4:594–602
Sullivan DA, Sullivan BD, Ullman MD et al (2000) Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci 41:3732–3741
Terry MA (2001) Dry eye in the elderly. Drugs Aging 18:101–107
Tsubota K (1998) Tear dynamics and dry eye. Prog Retin Eye Res 17:565–596
Tsubota K, Yamada M, Urayama K (1994) Spectacle side panels and moist inserts for the treatment of dry-eye patients. Cornea 13:197–201
Tsubota K, Goto E, Fujita H et al (1999) Treatment of dry eye by autologous serum application in Sjögren’s syndrome. Br J Ophthalmol 83:390–395
Tsubota K, Kawashima M, Inaba T et al (2010) The era of antiaging ophthalmology comes of age: antiaging approach for dry eye treatment. Ophthalmic Res 44:146–154
Uchino M, Nishiwaki Y, Michikawa T et al (2011) Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology. doi:10.1016/j.ophtha.2011.05.029
Utine CA, Stern M, Akpek EK (2010) Clinical review: topical ophthalmic use of cyclosporine A. Ocul Immunol Inflamm 18:352–361
Vivino FB, Al-Hashimi I, Khan Z et al (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome. Arch Intern Med 159:174–181
Wilson SE, Stulting RD (2007) Agreement of physician treatment practices with the international task force guidelines for diagnosis and treatment of dry eye disease. Cornea 26:284–289
Winfield AJ, Jessiman D, Williams A et al (1990) A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 74:477–480
World Health Organization (WHO) (2011) 10 facts on ageing and the life course. http://www.who.int/features/factfiles/ageing/en/index.html. Accessed 3 Nov 2011
Yokoi N, Komuro A, Nishii M et al (2005) Clinical impact of conjunctivochalasis on the ocular surface. Cornea 24:S24–S31
Yoo SE, Lee DC, Chang MH (2005) The effect of low dose doxycycline therapy in chronic meibomian gland dysfunction. Korean J Ophthalmol 19:258–263
Yoon KC, Jeong IY, Park YG et al (2007) Interleukin-6 and tumor necrosis factor-α levels in tears of patients with dry eye syndrome. Cornea 26:431–437
Yüksel B, Bozdag B, Acar M et al (2010) Evaluation of the effect of topical cyclosporine A with impression cytology in dry eye patients. Eur J Ophthalmol 20:675–679
Zoukhri D (2006) Effect of inflammation on lacrimal gland function. Exp Eye Res 82:885–898
Acknowledgments
Conflict of Interest: none; Ethical standards: Informed consent – not applicable; Animal rights – not applicable.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kashiwabuchi, F.K., Rodrigues, M.W., McDonnell, P.J. (2013). Dry Eye Syndrome in the Elderly: Challenges and Treatment Options. In: Scholl, H., Massof, R., West, S. (eds) Ophthalmology and the Ageing Society. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-36324-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-36324-5_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36323-8
Online ISBN: 978-3-642-36324-5
eBook Packages: MedicineMedicine (R0)